期刊文献+

宫腔管深度对膀胱直肠剂量的影响 被引量:1

The Effect of Tandem Depth on Bladder and Rectum Dose
原文传递
导出
摘要 目的:探讨宫颈癌根治性放射治疗患者用A点作为剂量参考点的后装中,宫腔管深度对膀胱直肠剂量的影响。方法:选取宫颈癌根治性放射治疗患者23例,宫体深度均大于6cm,处方剂量A点6Gy,通过改变源驻留点个数,模拟计算同一患者宫腔管深度在6cm、5cm、4cm、3cm时膀胱直肠的D2cc和D50,以6cm膀胱直肠数据为基准,对比分析宫腔管深度对膀胱直肠剂量的影响。结果:膀胱直肠的D2cc随宫腔管深度的增加而减小,与宫腔管深度在6cm相比,5cm、4cm、3cm时膀胱的平均值分别增加7c Gy、22c Gy、63c Gy(P=0.000),直肠的平均值分别增加13c Gy、37c Gy、93c Gy(P=0.000)。膀胱直肠的D50在宫腔管深度6cm、5cm、4cm时变化不大,膀胱的平均值分别为(227±33)c Gy、(226±34)c Gy、(228±34)c Gy,直肠的平均值分别为(182±28)c Gy、(181±28)c Gy、(184±27)c Gy,差异无统计学意义(P>0.05)。宫腔管深度在3cm深度时膀胱直肠的D50较6cm、5cm、4cm明显增加,膀胱平均值为(239±35)c Gy(P=0.001),直肠的平均值为(195±29)c Gy(P=0.000),差异有统计学意义。结论:对根治性放射治疗宫颈癌患者,用传统的A点作为剂量参考点,在保证宫腔管不穿出宫体的前提下增加宫腔管深度可以降低膀胱和直肠的剂量,这对于降低宫颈癌患者放疗并发症有重要意义。 Objective: To quantify the effects of tandem depth on bladder and rectum dose in conventional cervical cancer brachytherapy which used point A as dose reference point. Methods: Twenty three patients with cervical cancer whose depth of uterus was greater than 6cm were included in this study. The prescription dose was 6Gy to point A. 6cm,5cm,4cm,3cm of tandem depth were simulated in patients by changing the dwell source number. D2 ccand D50for bladder and rectum were calculated by treatment planning system. 6cm data of bladder and rectum was selected as a benchmark to compare and analyze the tandem depth effects on bladder and rectum dose. Results: The D2 ccof bladder and rectum decreased with the increase of tandem depth. Compared with 6cm,the mean value of bladder increased 7c Gy,22 c Gy,63 c Gy,P = 0. 000,the mean value of rectum increased 13 c Gy,37 c Gy,93 c Gy,P = 0. 000 in the case when 5cm,4cm,3cm tandem depth were adopted respectively. The changes of bladder and rectum D50 in 6cm,5cm,4cm were small,the average value of bladder were( 227 ± 33) c Gy,( 226 ± 34) c Gy,( 228 ± 34) c Gy,the average value of rectum were( 182 ±28) c Gy,( 181 ± 28) c Gy,( 184 ± 27) c Gy,with no statistical difference. When the tandem depth decreased to 3cm,the D50 of bladder and rectum increased significantly with the average value of bladder was( 239 ± 35) c Gy( P = 0. 001),the average value of rectum was( 195 ± 29) c Gy( P = 0. 000). Conclusion: For cervical cancer patients who accepting brachytherapy which use point A as dose reference point,increasing tandem depth can reduce bladder and rectum dose and of great significance for reducing the complications of patients under the guarantee that tandem do not wear out from uterine.
出处 《肿瘤预防与治疗》 2015年第5期253-257,共5页 Journal of Cancer Control And Treatment
基金 四川省科技支撑计划项目"女性肿瘤疾病的综合防治研究" 项目编号:2014SZ0001
关键词 宫颈癌 后装放疗 宫腔管深度 膀胱直肠剂量 Cervical cancer Brachytherapy Tandem Depth Bladder and Rectum Dose
  • 相关文献

参考文献15

  • 1Lanciano RM, Won M,Coia LH, et al. Pretreatment and treat-ment factors associated with improved outcome in squamous cellcarcinoma of the uterine cervix : a final report of the 1973 and1978 patterns of care studies [ J ]. Int J Radiat Oncol Biol Phys,1991,20(4):667 -676.
  • 2Viswanathan AN, Cormack R, Rawal B, et al. Increasing brachy-therapy dose predicts survival for interstitial and tandem-based ra-diation for stage IIIB cervical cancer [ J ]. Int J Gynecol Cancer,2009,19(8):1402-1406.
  • 3Tod M,Meredith WJ. Treatment of cancer of the cervix uteri-arevised “Manchester Method^ [ J]. Br J Radiol, 1953 ,26(305):252 -257.
  • 4Kim RY, Shen S, Lin HY, et al. Effects of bladder distension onorgans at risk in 3D image-based planning of intracavitary brachy-therapy for cervical cancer [ J ]. Int J Radiat Oncol Biol Phys,2010,76(2) :485 -489.
  • 5Lim J, Durbin-Johnson B, Valicenti R, et al. The impact of maxi-mum rectal distention and tandem angle on rectal dose delivered in3D planned gynecologic high dose-rate brachytherapy [ J]. Int JGynecol Cancer,2013 ,23 (6) :1078 -1083.
  • 6Talluri AK, Alluri KR, Gudipudi DK, et al. Study of positionalhigh-dose-rate brachytherapy in cervical cancer patients [ J ]. JMed Phys,2013,38(4) : 178 -184.
  • 7Marosevic G, Ljuca D, Osmic H, et al. Inter-application dis-placement of brachytherapy dose received by the bladder and rec-tum of the patients with inoperable cervical cancer [ J ]. Radiol0ncol,2014,48(2) :203 -209.
  • 8Viswanathan AN, Beriwai S, De Los Santos JF, et al. AmericanBrachytherapy Society consensus guidelines for locally advancedcarcinoma of the cervix. Part II: high-dose-rate brachytherapyL [J]. Brachytherapy,2012,11(1) :47 -52.
  • 9Lindegaard JC, Tanderup K, Nielsen SK, et al. MRI-guided 3Doptimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer[ J].Int J Radiat Oncol Biol Phys,2008,71 (3) :756 -764.
  • 10De Brabandere M, Mousa AG, Nulens A, et al. Potential of doseoptimisation in MRI-based PDR brachytherapy of cervix carcinoma[J]. Radiother Oncol,2008,88(2) :217 -226.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部